NAUTILUS BIOTECHNOLOGY INC
NAUT·63909J108·US·Common Stock·Healthcare - Biotechnology-Activist
NAUT (NAUTILUS BIOTECHNOLOGY INC) is held by 45 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($9.9M), MILLENNIUM MANAGEMENT LLC ($4.9M), GEODE CAPITAL MANAGEMENT, LLC ($2.3M). Net institutional sentiment: Mixed.
45
Holders
Avg rating(9 Elite)
$29.4M
Total Value
62% (51)
Fund Consensus
28 buying - 17 selling
Who's Trading
ActivistABAH Bio Fund II, L.P.6.6%Jun 30, 2026
ActivistABAH Bio Fund II, L.P.9.2%Jun 4, 2026
InsiderPMPatel Sujal MBuy $65KMar 4, 2026
ActivistSPSujal Patel16.3%Mar 4, 2026
ActivistPMParag Mallick17.6%Mar 4, 2026
InsiderSKSuzuki KentaroBuy $6KNov 6, 2025
InsiderPMPatel Sujal MBuy $57KSep 8, 2025
InsiderPMPatel Sujal MBuy $79KSep 5, 2025
InsiderMBMurphy Matthew B.Buy $13KSep 4, 2025
ActivistPAPerceptive Advisors LLC10.1%Jun 24, 2025
13F: Insider & Congress:
Showing 1-20 of 51
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer